NR3C2 and breast cancer: While MR expression is on average lower in breast cancer than in normal breast tissue, we found that MR is present in a subset of breast cancers, and MR-RARB dual positivity is predictive of better breast cancer-specific survival in the METABRIC breast cancer cohort.